Matt Callahan

Matt Callahan is an experienced researcher and consultant with a strong background in molecular chaperones, chemical proteomics, and investment strategy in the biotech sector. Currently, as a Graduate Student Researcher at the University of California, San Francisco's Gestwicki Lab, Matt focuses on the discovery of substrates for the E3 ligase CHIP and conducts assays for specificity profiling. Additionally, Matt serves as a consultant for RA Capital Management, providing scientific strategy for a covalent chemistry company, and as VP of Operations and Partner at EVEXIA Bio Fund, where responsibilities include creating investment theses and guiding analysts. Previous roles include Vice President of Due Diligence at Biotech Connection - Bay Area and PDRP Associate Engineer at Genentech, complemented by educational achievements that include a PhD in Chemistry and Chemical Biology from the University of California, San Francisco and a BS in Chemical Engineering from Stanford University.